GEENOR recommends Windows Mobile phones.
home
 
 

Sequencing of entire human genome

Human genome refers to effort of sequencing and mapping of the entire human DNA. This work is being done two ways: firstly by HGP - Human Genome Project (see http://www.nhgri.nih.gov/HGP/ ) - an international and inter-institutional research effort; and secondly by several private companies like Celera (see http://www.celera.com ) owned by Mr. Ventair. It is expected that the sequencing will be completed about year 2002.

Mr. Ventair got from private investors over 300 millions of US dollars. He claims that his company Celera will get results earlier than HGP, but he, after completion of sequencing of the whole human genome, wishes to provide results to interested parties with delays and for money. At least he does not require from his customers, i.e. those who will buy access to his databases, that he will obtain copyrights of technologies developed on the basis of these databases - some other private companies require for example participation in property of patents developed with help of their databases!

Celera's technique relies on splitting of the whole human genome into pieces and then putting them together. HGP on the other hand is going through whole genome step by step forwards.

See below some photos related to sequencing of the human genome.

dna10_1.jpg (9697 bytes)
Photo 1: Francis Colling, boss of Human Genome Project.

dna10_2.jpg (24379 bytes)
Photo 2: Screen-shot of the software used in the sequencing.

dna10_3.jpg (6017 bytes)
Photo 3: Another screen-shot of the software used in the sequencing.

dna10_4.jpg (22549 bytes)
Photo 4: Yet another screen-shot of the software used in the sequencing.

dna10_5.jpg (11660 bytes)
Photo 5: Craig Venter, owner of Celera Genomics.

dna10_6.jpg (7183 bytes)
Photo 6: Laboratory at Celera where sequencing takes place.

dna10_7.jpg (9387 bytes)
Photo 7: Another scene from laboratory at Celera where sequencing takes place.


home
 
 

Page 0032. Version: 0001. Copyright by: GEENOR. All rights reserved.